Login / Signup

Hijacking Methyl Reader Proteins for Nuclear-Specific Protein Degradation.

Dhanusha A NalawanshaKe LiJohn HinesCraig M Crews
Published in: Journal of the American Chemical Society (2022)
Targeted protein degradation (TPD) by PROTACs is a promising strategy to control disease-causing protein levels within the cell. While TPD is emerging as an innovative drug discovery paradigm, there are currently only a limited number of E3 ligase:ligand pairs that are employed to induce protein degradation. Herein, we report a novel approach to induce protein degradation by hijacking a methyl reader:E3 ligase complex. L3MBTL3 is a methyl-lysine reader protein that binds to the Cul4 DCAF5 E3 ligase complex and targets methylated proteins for proteasomal degradation. By co-opting this natural mechanism, we report the design and biological evaluation of L3MBTL3-recruiting PROTACs and demonstrate nuclear-specific degradation of FKBP12 and BRD2. We envision this as a generalizable approach to utilize other reader protein-associated E3 ligase complexes in PROTAC design to expand the E3 ligase toolbox and explore the full potential of TPD.
Keyphrases
  • protein protein
  • amino acid
  • drug discovery
  • mesenchymal stem cells
  • single cell
  • drug delivery
  • bone marrow
  • cancer therapy
  • cell therapy